Prostate Cancer Therapeutics Market 2019 Analysis By Product Type, Application , Key regions, Companies, Current Trend & Growth Till 2025

This report studies the global market size of prostate cancer therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of prostate cancer therapeutics in these regions.

This research report categorizes the global prostate cancer therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

To request PDF sample copy of this report:

Key Developments in the Market:

In May 2018, Ferring Pharmaceuticals has done an agreement giving the company the option to secure global commercialisation rights to nadofaragene firadenovec/Syn3 (rAd-IFN/Syn3), a novel gene therapy that is being developed by FKD Therapies Oy (FKD) as a treatment for patients with high-grade non-muscle invasive bladder cancer (NMIBC), who are unresponsive to Bacillus Calmette-Guérin (BCG) therapy. This option is exercisable on marketing approval from the US FDA. This will create a new US oncology division with the specialist knowledge and presence to introduce novel advanced therapies to the market.

Market Definition: Global Prostate Cancer Therapeutics Market

The prostate cancer occurs in the prostate which is a small walnut shaped gland. The prostate cancer is most common type in men. Due to increase in awareness regarding the symptoms among the people, the market for the prostate cancer therapeutics is growing at a high growth rate. Various developments in advance science are helping in development of launch of various options for the treatment of this disease.

According to an article published recently by the cancer research institute in U.K., around 11,287 deaths were registered due to prostate cancer in U.K. The prostate cancer is the fourth most prevalent cancer globally. Various researches are made by the key player for the development of the therapies for the treatment of the cancer.

The government is also taking various measures for the awareness regarding symptoms of the prostate cancer and availability of screening & diagnostic tests such as Prostate-Specific Antigen (PSA) and Digital Rectal Exam (DRE) resulting in early detection. Hence, such initiatives by the government and the key players help in the growth of the market.

Major Market Drivers and Restraints:

  • Innovative drugs driving the market
  • Increase in research & development in oncology therapeutic area
  • Developments in genomics & proteomics
  • Adverse events of treatment
  • Cost associated with the treatment
  • Low success rate in clinical testing for oncology drugs

Click Here for Table of Content to Better Understanding of Report @  

Top Key Players:

  • Tolmar INC,
  • Ferring Pharmaceuticals,
  • Takeda pharmaceutical co. Ltd.,
  • Teva Pharmaceutical Industries LTD,
  • Sanofi-Aventis, Pfizer Inc,
  • Johnson & Johnson,
  • IPSEN,
  • Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc) ,
  • Dendreon Corporation,
  • Abbott Laboratories,
  • Bayer AG,
  • Dendreon Corporation (Sanpower Group Co. Ltd.),
  • AbbVie, Inc.  among others.

Competitive Analysis: 

The global prostate cancer therapeutics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of prostate cancer therapeutics market for global, Europe, North America, Asia Pacific and South America.

Major Topics Covered:

1.            Introduction

2.            Market Segmentation

3.            Executive Summary

4.            Market Overview

5.            Premium Insights

6.            Global Prostate Cancer Therapeutics Market:  Regulatory Scenario

7.            Global Prostate Cancer Therapeutics Market, By Drug Type

8.            Global Prostate Cancer Therapeutics Market, By Distribution Channel

9.            Global Prostate Cancer Therapeutics Market, By End User

10.          Global Prostate Cancer Therapeutics, By Geography

11.          Global Prostate Cancer Therapeutics, Company Landscape

12.          Company Profiles

13.          Related Reports

Any Questions? Inquiry before Buying Visit @

Report Overview:

On the basis of drug type, the market is classified into

  • Hormonal therapy,
  • Luteinizing hormone-releasing hormone (lhrh) agonist,
  • Anti-androgens,
  • Immunotherapy,
  • Targeted therapy,
  • Chemotherapy

On the basis of distribution channel

  • Hospital pharmacies,
  • Retail pharmacies,
  • Online pharmacies

Based on geography

  • North america & south america,
  • Europe,
  • Asia-pacific
  • Middle east & africa

Key reason to Purchase the report

1.         To describe and forecast the prostate cancer therapeutics market, in terms of value, by process, product type, and industry.

2.         To strategically profile key players and comprehensively analyze their market position in terms of ranking and core competencies, and detail the competitive landscape for market leaders

3.         To describe and forecast the market, in terms of value, for various segments, by region North America, Europe, Asia Pacific (APAC), and Rest of the World (RoW)

4.         To provide detailed information regarding the major factors (drivers, restraints, opportunities, and challenges) influencing the MID market growth

5.         Market Development: Comprehensive information about emerging markets. This report analyzes the market for various trocars across geographies.

6.         To strategically analyze micro markets with respect to individual growth trends, prospects, and contribution to the overall market

Questions? We’ll Put You On The Right Path Request Analyst Call @

Related Report

Global Revenue Cycle Management (RCM) Market – Industry Trends and Forecast to 2024

Global Revenue Cycle Management (RCM) Market By Product Type (Integrated RCM, Standalone RCM), By Stage (Front Office, Mid Office, Back Office), By End User (Hospitals, General Physicians, Labs, Others), By Deployment (Web-based, On-premise, Cloud-based), By Component (Software, Services), By Geography (North America, Europe, Asia Pacific, South America, Middle East & Africa) –Industry Trends and Forecast to 2024

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Sopan Gedam

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Posted by on Friday January 11 2019, 9:57 AM EDT. All trademarks acknowledged. Filed under Business, Featured News, Featured Press Release, Health, Healthcare. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in